product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
Resazurin
catalog :
AR002
quantity :
100 mL
price :
166 USD
more info or order :
citations: 40
Reference
Lane A, Scher N, Bhattacharjee S, Zlatic S, ROBERTS A, Gokhale A, et al. Adaptive protein synthesis in genetic models of copper deficiency and childhood neurodegeneration. bioRxiv. 2024;: pubmed publisher
Harris E, Sharpe J, Strozen T, Abdi S, Kliewer M, Sanchez M, et al. The EphA2 Receptor Regulates Invasiveness and Drug Sensitivity in Canine and Human Osteosarcoma Cells. Cells. 2024;13: pubmed publisher
Wei T, Zeng C, Li Q, Xiao Z, Zhang L, Zhang Q, et al. FOXM1/DEPDC1 feedback loop promotes hepatocarcinogenesis and represents promising targets for cancer therapy. Cancer Sci. 2024;115:3041-3053 pubmed publisher
Pilarte K, Reichert E, Green Y, Halberg L, McFarland S, Mimche P, et al. HAF Prevents Hepatocyte Apoptosis and Hepatocellular Carcinoma through Transcriptional Regulation of the NF-κB pathway. bioRxiv. 2024;: pubmed publisher
Hababag E, Cauilan A, Quintero D, Bermudes D. Tryptophanase Expressed by Salmonella Halts Breast Cancer Cell Growth In Vitro and Inhibits Production of Immunosuppressive Kynurenine. Microorganisms. 2023;11: pubmed publisher
Ryoo H, Underhill G. Combinatorial Microgels for 3D ECM Screening and Heterogeneous Microenvironmental Culture of Primary Human Hepatic Stellate Cells. bioRxiv. 2023;: pubmed publisher
Hnatiuk A, Bruyneel A, Tailor D, Pandrala M, Dheeraj A, Li W, et al. Reengineering Ponatinib to Minimize Cardiovascular Toxicity. Cancer Res. 2022;82:2777-2791 pubmed publisher
Hall A, Pohl S, Cammareri P, Aitken S, Younger N, Raponi M, et al. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer. Nat Commun. 2022;13:2791 pubmed publisher
Luu A, Cadieux M, Wong M, Macdonald R, Jones R, Choi D, et al. Proteomic Assessment of Extracellular Vesicles from Canine Tissue Explants as a Pipeline to Identify Molecular Targets in Osteosarcoma: PSMD14/Rpn11 as a Proof of Principle. Int J Mol Sci. 2022;23: pubmed publisher
Smith A, Ferraro E, Safonov A, Morales C, Lahuerta E, Li Q, et al. HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nat Commun. 2021;12:6667 pubmed publisher
Rothhammer Hampl T, Liesenberg F, Hansen N, Hoja S, Delic S, Reifenberger G, et al. Frequent Epigenetic Inactivation of DIRAS-1 and DIRAS-2 Contributes to Chemo-Resistance in Gliomas. Cancers (Basel). 2021;13: pubmed publisher
T xf3 th M, Wehling L, Thiess L, Rose F, Schmitt J, Weiler S, et al. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma. BMC Cancer. 2021;21:1079 pubmed publisher
Peeri H, Shalev N, Vinayaka A, Nizar R, Kazimirsky G, Namdar D, et al. Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro. Cancers (Basel). 2021;13: pubmed publisher
Zhao X, Wang M, Jiang H, Lwin T, Park P, Gao J, et al. Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma. Cell Rep. 2021;34:108870 pubmed publisher
Lee J, Robinson M, Ma N, Artadji D, Ahmed M, Xiao G, et al. IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature. 2020;588:491-497 pubmed publisher
Lee L, Khakoo A, Chintalgattu V. Cardiac pericytes function as key vasoactive cells to regulate homeostasis and disease. FEBS Open Bio. 2021;11:207-225 pubmed publisher
Wang Q, Qian B, Sch xe4 fer M, Gro xdf W, Mehrabi A, Ryschich E. Fluorescence-guided fiber-optic micronavigation using microscopic identification of vascular boundary of liver segment and tumors. Theranostics. 2020;10:6136-6148 pubmed publisher
Braun L, Lagies S, Guenzle J, Fichtner Feigl S, Wittel U, Kammerer B. Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines. Cells. 2020;9: pubmed publisher
Chau Y, Li F, Levsh O, Weng J. Exploration of icariin analog structure space reveals key features driving potent inhibition of human phosphodiesterase-5. PLoS ONE. 2019;14:e0222803 pubmed publisher
Goeppert B, Renner M, Singer S, Albrecht T, Zhang Q, Mehrabi A, et al. Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma. Sci Rep. 2019;9:4338 pubmed publisher
Schott C, Ludwig L, Mutsaers A, Foster R, Wood G. The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells. PLoS ONE. 2018;13:e0206427 pubmed publisher
Ren Y, Bi C, Zhao X, Lwin T, Wang C, Yuan J, et al. PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas. J Clin Invest. 2018;128:5517-5530 pubmed publisher
Li J, Xing F, Chen F, He L, So K, Liu Y, et al. Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages. Cell Transplant. 2019;28:510-521 pubmed publisher
Gala K, Li Q, Sinha A, Razavi P, Dorso M, Sanchez Vega F, et al. KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function. Oncogene. 2018;37:4692-4710 pubmed publisher
Schulze M, Hutterer M, Sabo A, Hoja S, Lorenz J, Rothhammer Hampl T, et al. Chronophin regulates active vitamin B6 levels and transcriptomic features of glioblastoma cell lines cultured under non-adherent, serum-free conditions. BMC Cancer. 2018;18:524 pubmed publisher
El Zawily A, McEwen E, Toosi B, Vizeacoumar F, Freywald T, Vizeacoumar F, et al. The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment. Sci Rep. 2017;7:14767 pubmed publisher
Clarke P, Ortiz Ruiz M, TePoele R, Adeniji Popoola O, Box G, Court W, et al. Assessing the mechanism and therapeutic potential of modulators of the human Mediator complex-associated protein kinases. elife. 2016;5: pubmed publisher
Pastor Cavada E, Pardo L, Kandil D, Torres Fuentes C, Clarke S, Shaban H, et al. A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo. Sci Rep. 2016;6:36456 pubmed publisher
Song H, Fares M, Maguire K, Sidén A, Potácová Z. Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS ONE. 2014;9:e114457 pubmed publisher
Torres Fuentes C, Theeuwes W, McMullen M, McMullen A, Dinan T, Cryan J, et al. Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extract. PLoS ONE. 2014;9:e103118 pubmed publisher
Bates D, Abraham S, Campbell M, Zehbe I, Curiel L. Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging. PLoS ONE. 2014;9:e97220 pubmed publisher
Chung M, Dean S, Marakasova E, Nwabueze A, van Hoek M. Chitinases are negative regulators of Francisella novicida biofilms. PLoS ONE. 2014;9:e93119 pubmed publisher
Ehsanipour E, Sheng X, Behan J, Wang X, Butturini A, Avramis V, et al. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. Cancer Res. 2013;73:2998-3006 pubmed publisher
Smith R, O Bryan L, Farrow E, Summers L, Clinkenbeard E, Roberts J, et al. Circulating ?Klotho influences phosphate handling by controlling FGF23 production. J Clin Invest. 2012;122:4710-5 pubmed publisher
Gammoh N, Lam D, Puente C, Ganley I, Marks P, Jiang X. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death. Proc Natl Acad Sci U S A. 2012;109:6561-5 pubmed publisher
Jalava S, Urbanucci A, Latonen L, Waltering K, Sahu B, Janne O, et al. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene. 2012;31:4460-71 pubmed publisher
Maddigan A, Truitt L, Arsenault R, Freywald T, Allonby O, Dean J, et al. EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes. J Immunol. 2011;187:5983-94 pubmed publisher
O Callaghan G, Kelly J, Shanahan F, Houston A. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. Br J Cancer. 2008;99:502-12 pubmed publisher
Liu J, Dolan M, Reidy M, Cramer C. Expression of bioactive single-chain murine IL-12 in transgenic plants. J Interferon Cytokine Res. 2008;28:381-92 pubmed publisher
Schwartz P, Manion M, Emerson C, Fry J, Schulz C, Sweet I, et al. 2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition. Mol Cancer Ther. 2007;6:2073-80 pubmed
product information
master code :
AR002
SKU :
AR002
product name :
Resazurin
unit size :
100 mL
target :
Cell Viability/Proliferation Assays
category :
Activity Assays
USD :
166 USD
storage :
Store the unopened product at 2 - 8 ░C. Protect from light. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.